FdaApplication
NDA 202813
Identifiers
- fda_app_no: NDA202813
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLC |
| application_type | NDA |
| approval_date | 2012-03-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| QNASL | BECLOMETHASONE DIPROPIONATE | 0.04MG/ACTUATION | AEROSOL, METERED;NASAL |
| QNASL | BECLOMETHASONE DIPROPIONATE | 0.08MG/ACTUATION | AEROSOL, METERED;NASAL |
2 products